biote Corp.: Bandera Partners LLC amends Schedule 13G stake filing
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Bandera Partners LLC amended its Schedule 13G filing for biote Corp., disclosing a revised passive stake in the company via SEC accession 0000921895-26-003039. The filing updates the investment firm's previously reported ownership position in the hormone therapy provider. Schedule 13G amendments are typically filed when a passive investor's stake crosses or adjusts past the 5% threshold, though the headline did not specify the exact percentage held. The change matters because it signals a shift in a significant institutional holder's position in biote. Investors will watch for the full filing details to confirm the precise share count and any change in voting authority.
Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.
Named in this story
Bandera Partners LLC, biote Corp.